Agios to Webcast Conference Call of Fourth Quarter and Full Year 2016 Financial Results on February 16, 2017 Read more about Agios to Webcast Conference Call of Fourth Quarter and Full Year 2016 Financial Results on February 16, 2017
Agios Announces Key Upcoming Milestones to Support Evolution to a Commercial Stage Biopharmaceutical Company in 2017 Read more about Agios Announces Key Upcoming Milestones to Support Evolution to a Commercial Stage Biopharmaceutical Company in 2017
Agios and Celgene Establish New Collaboration in Metabolic Immuno-Oncology and Amend Certain Rights from 2010 Agreement Read more about Agios and Celgene Establish New Collaboration in Metabolic Immuno-Oncology and Amend Certain Rights from 2010 Agreement
Agios Appoints Ian Clark to Board of Directors Read more about Agios Appoints Ian Clark to Board of Directors
Agios to Present at the 35th Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2017 Read more about Agios to Present at the 35th Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2017
Agios Announces New Clinical Data from Dose-Escalation Portion of Phase 1 Trial of Single Agent AG-120 Showing Durable Molecular Responses in Patients with Advanced Hematologic Malignancies Read more about Agios Announces New Clinical Data from Dose-Escalation Portion of Phase 1 Trial of Single Agent AG-120 Showing Durable Molecular Responses in Patients with Advanced Hematologic Malignancies
Agios Announces New Data from AG-348 and AG-519 Demonstrating Potential for First Disease-modifying Treatment for Patients with PK Deficiency Read more about Agios Announces New Data from AG-348 and AG-519 Demonstrating Potential for First Disease-modifying Treatment for Patients with PK Deficiency
Agios Announces Phase 1 Data from Dose Expansion Cohorts of AG-120 in Patients with IDH1 Mutant Positive Glioma and Chondrosarcoma Read more about Agios Announces Phase 1 Data from Dose Expansion Cohorts of AG-120 in Patients with IDH1 Mutant Positive Glioma and Chondrosarcoma
Agios to Present New Data from PKR and IDH Programs at the 2016 ASH Annual Meeting Read more about Agios to Present New Data from PKR and IDH Programs at the 2016 ASH Annual Meeting